Figure 1 (Clopidogrel 01)
Clopidogrel Tablet, Film Coated
Product Images NDC 82804-986
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Clopidogrel (NDC 82804-986). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Clopidogrel 02)
Figure 2 (Clopidogrel 03)
This is a data table showing the cumulative event rate for cardiovascular death, myocardial infarction, and stroke over a period of 12 months. It compares the outcomes between Plagebo (aspirin) and Clopidogrel (aspirin). The P-value indicates a significant difference between the two treatment groups. Other standard therapies were also used during the study.*
Figure 3 (Clopidogrel 04)
Figure 3 (Clopidogrel 05)
Figure 4 (Clopidogrel 06)
This text presents statistics on mortality rates in a study comparing a placebo group with a group taking Clopidogrel. The data shows that 1845 deaths (8.1%) occurred in the placebo group compared to 1726 deaths (7.5%) in the Clopidogrel group. The study found a 7% proportional risk reduction in mortality among those taking Clopidogrel, with a significance level of p=0.03. The text seems to end with a reference to days since randomization.*
Figure 5 (Clopidogrel 07)
This text provides a comparative analysis between a placebo and clopidogrel in terms of the percentage of individuals experiencing death, re-infarction, or stroke before discharge. It states the number of individuals with events for each treatment group and demonstrates a 9% proportional risk reduction with clopidogrel compared to placebo, with a p-value of 0.002. The data also includes a time chart showing the number of days since randomization up to 28 days.*
Figure 6 (Clopidogrel 08)
Figure 7 (Clopidogrel 09)
Not available.*
Figure 8 (Clopidogrel 10)
82804-986-30 (Clopidogrel 11)
This text provides information about a medication called Clopidogrel 300mg, which comes in a pack of 30 tablets. It mentions the dosage, components, appearance, manufacturer (ScieGen Pharmaceuticals, Inc.), and storage instructions. Additionally, it advises to dispense the Medication Guide to each patient, provides the product ID, and cautions to keep the medication out of the reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
